Mechanical thrombectomy is efficacious in patients with pre-stroke moderate disability.

Abstract

INTRODUCTION\nPatients with ischaemic stroke due to large vessel occlusion (LVO) can be treated successfully with mechanical thrombectomy (MT) and/or intravenous thrombolysis. In the landmark trials, MT was only performed for those with no functional disability prior to stroke (mRS 0-2). There are limited data available regarding clinical outcomes for patients with pre-stroke moderate disability (mRS\xa0≥\xa03). The aims of this study were to analyse the clinical outcomes and financial implications in regard to accommodation costs of performing MT in patients with pre-stroke mRS\xa0=\xa03.\n\n\nMETHODS\nAn observational cohort study was performed of 802 patients with anterior circulation LVO ischaemic stroke who underwent MT between October 2016 and January 2020 at three tertiary hospitals. Patient demographics, premorbid mRS, stroke and interventional data, 90-day mRS and accommodation situation were recorded.\n\n\nRESULTS\nEighty-two patients with anterior circulation LVO ischaemic stroke were pre-stroke mRS 3. 38% had a good clinical outcome, as defined by mRS 3 at 90\xa0days. Mortality rate was 38%. The majority of patients presented from home (83%) and greater than one third of those returned home during the 90\xa0days post treatment. 81% of patients had no increase in accommodation cost at 90\xa0days.\n\n\nCONCLUSION\nPatients with pre-stroke moderate disability may benefit from MT if they are appropriately selected. This may result in fewer patients requiring nursing home placement and less financial burden on the public health system, indicating significant savings are possible.